S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
Sell every Stock except ONE (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
Biden and McCarthy reach a final deal to avoid US default and now must sell it to Congress
BREAKING: Tiny biotech successfully treats blindness (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
BREAKING: Tiny biotech successfully treats blindness (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
Sell every Stock except ONE (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
Biden and McCarthy reach a final deal to avoid US default and now must sell it to Congress
BREAKING: Tiny biotech successfully treats blindness (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
BREAKING: Tiny biotech successfully treats blindness (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
Sell every Stock except ONE (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
Biden and McCarthy reach a final deal to avoid US default and now must sell it to Congress
BREAKING: Tiny biotech successfully treats blindness (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
BREAKING: Tiny biotech successfully treats blindness (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
Sell every Stock except ONE (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
Biden and McCarthy reach a final deal to avoid US default and now must sell it to Congress
BREAKING: Tiny biotech successfully treats blindness (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
BREAKING: Tiny biotech successfully treats blindness (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
NASDAQ:AVGR

Avinger (AVGR) Stock Forecast, Price & News

$0.57
-0.02 (-3.41%)
(As of 05/26/2023 ET)
Compare
Today's Range
$0.56
$0.60
50-Day Range
$0.43
$0.83
52-Week Range
$0.42
$2.10
Volume
36,738 shs
Average Volume
101,400 shs
Market Capitalization
$6.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Avinger MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
2.97% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.96mentions of Avinger in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$181 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.21) to ($0.68) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.64 out of 5 stars


AVGR stock logo

About Avinger (NASDAQ:AVGR) Stock

Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Wildcat, Juicebox, and Kittycat. The company was founded by John B. Simpson and Himanshu N. Patel on March 8, 2007 and is headquartered in Redwood City, CA.

Receive AVGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter.

AVGR Stock News Headlines

Avinger Inc AVGR Stock Quote
15 A.I. Trading Opportunities a Day
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
StockNews.com Initiates Coverage on Avinger (NASDAQ:AVGR)
Avinger: Q1 Earnings Snapshot
Avinger Reports First Quarter 2023 Results
15 A.I. Trading Opportunities a Day
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
Avinger (NASDAQ:AVGR) Now Covered by StockNews.com
Avinger (NASDAQ:AVGR) Now Covered by Analysts at StockNews.com
Avinger (NASDAQ:AVGR) Coverage Initiated at StockNews.com
Avinger Reports Fourth Quarter 2022 Results
Avinger Announces 510(k) Filing of Pantheris LV
Avinger Reports Third Quarter 2022 Results
See More Headlines
Receive AVGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter.

AVGR Company Calendar

Last Earnings
3/15/2023
Today
5/28/2023
Next Earnings (Estimated)
8/10/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AVGR
Employees
68
Year Founded
N/A

Profitability

Net Income
$-17,620,000.00
Net Margins
-207.02%
Pretax Margin
-207.02%

Debt

Sales & Book Value

Annual Sales
$8.27 million
Book Value
($0.14) per share

Miscellaneous

Free Float
10,635,000
Market Cap
$6.05 million
Optionable
Not Optionable
Beta
1.52

Key Executives

  • Jeffrey M. Soinski
    President, Chief Executive Officer & Director
  • Nabeel Subainati
    Chief Financial & Accounting Officer
  • Himanshu N. Patel
    Chief Technology Officer
  • Jaafer Golzar
    Chief Medical Officer
  • Philip R. Preuss
    Chief Marketing Officer & VP-Business Operations













AVGR Stock - Frequently Asked Questions

Should I buy or sell Avinger stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AVGR shares.
View AVGR analyst ratings
or view top-rated stocks.

How have AVGR shares performed in 2023?

Avinger's stock was trading at $1.0850 on January 1st, 2023. Since then, AVGR shares have decreased by 47.8% and is now trading at $0.5660.
View the best growth stocks for 2023 here
.

Are investors shorting Avinger?

Avinger saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 317,000 shares, a decline of 48.6% from the April 30th total of 616,600 shares. Based on an average trading volume of 241,400 shares, the days-to-cover ratio is presently 1.3 days. Approximately 3.0% of the shares of the stock are sold short.
View Avinger's Short Interest
.

When is Avinger's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our AVGR earnings forecast
.

How were Avinger's earnings last quarter?

Avinger, Inc. (NASDAQ:AVGR) issued its quarterly earnings results on Wednesday, March, 15th. The medical device company reported ($0.70) earnings per share for the quarter. The medical device company had revenue of $2 million for the quarter. Avinger had a negative trailing twelve-month return on equity of 530.21% and a negative net margin of 207.02%.

When did Avinger's stock split?

Avinger's stock reverse split on Tuesday, March 15th 2022. The 1-20 reverse split was announced on Tuesday, March 15th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, March 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Avinger own?
When did Avinger IPO?

(AVGR) raised $60 million in an IPO on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

What is Avinger's stock symbol?

Avinger trades on the NASDAQ under the ticker symbol "AVGR."

Who are Avinger's major shareholders?

Avinger's stock is owned by a variety of institutional and retail investors. Top institutional investors include Armistice Capital LLC (4.38%). Insiders that own company stock include Himanshu Patel, James Cullen, Jeffrey M Soinski, Mark Weinswig and Nabeel Paul Subainati.
View institutional ownership trends
.

How do I buy shares of Avinger?

Shares of AVGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avinger's stock price today?

One share of AVGR stock can currently be purchased for approximately $0.57.

How much money does Avinger make?

Avinger (NASDAQ:AVGR) has a market capitalization of $6.05 million and generates $8.27 million in revenue each year. The medical device company earns $-17,620,000.00 in net income (profit) each year or ($3.12) on an earnings per share basis.

How can I contact Avinger?

Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The official website for the company is www.avinger.com. The medical device company can be reached via phone at (650) 241-7900, via email at info@dawson3d.com, or via fax at 800-229-2696.

This page (NASDAQ:AVGR) was last updated on 5/28/2023 by MarketBeat.com Staff

My Account -